Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solomon Tesfaye

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Frontiers in Endocrinology|December 12, 2022
Changed cerebral function and morphology serve as neuroimaging evidence for subclinical type 2 diabetic polyneuropathyLin-Mei Zhao, Xin Chen, You-Ming Zhang, et al.
Journal of Diabetes and Its Complications|March 11, 2023
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countriesSolomon Tesfaye, Silviu Brill, Mariëlle Eerdekens, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 1, 2021
Reduced Thalamic Volume and Metabolites in Type 1 Diabetes with PolyneuropathyTine M Hansen, Jens B Frøkjær, Dinesh Selvarajah, et al.
Pain and Therapy|June 24, 2024
Efficacy and Safety of Trazodone and Gabapentin Fixed-Dose Combination in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose-Finding StudySolomon Tesfaye, Ponnusamy Saravanan, Edvard Ehler, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 11, 2018
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTIONAaron I Vinik, Pauline M Camacho, Jaime A Davidson, et al.
BMJ Open|November 27, 2025
Evaluating pain and neurological function with high frequency 10 kHz spinal cord stimulation in the treatment of painful diabetic neuropathy: design of a multicentre, randomised controlled trial (PDN-Sensory)Rodica Pop-Busui, Erika A Petersen, Brian L Levy, et al.
Eclinicalmedicine|October 13, 2025
Spinal cord stimulation for the treatment of painful diabetic neuropathy and risk of major adverse cardiovascular events, mortality, amputation, infection and suicide: a retrospective cohort studyAlex E Henney, Bernhard Frank, David R Riley, et al.
Diabetes Care|September 30, 2010
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatmentsSolomon Tesfaye, Andrew J M Boulton, Peter J Dyck, et al.
Diabetes, Obesity & Metabolism|June 11, 2025
The use of SGLT2 inhibitors in people with diabetes-related foot disease: A Delphi-based consensus studyPatrick Highton, Ruksar Abdala, Rachel Evley, et al.
Diabetes/Metabolism Research and Reviews|February 16, 2024
Brain alterations in regions associated with end-organ diabetic microvascular disease in diabetes mellitus: A UK Biobank studyJamie Burgess, Christophe de Bezenac, Simon S Keller, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Frontiers in Endocrinology|December 12, 2022
Changed cerebral function and morphology serve as neuroimaging evidence for subclinical type 2 diabetic polyneuropathyLin-Mei Zhao, Xin Chen, You-Ming Zhang, et al.
Journal of Diabetes and Its Complications|March 11, 2023
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countriesSolomon Tesfaye, Silviu Brill, Mariëlle Eerdekens, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 1, 2021
Reduced Thalamic Volume and Metabolites in Type 1 Diabetes with PolyneuropathyTine M Hansen, Jens B Frøkjær, Dinesh Selvarajah, et al.
Pain and Therapy|June 24, 2024
Efficacy and Safety of Trazodone and Gabapentin Fixed-Dose Combination in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose-Finding StudySolomon Tesfaye, Ponnusamy Saravanan, Edvard Ehler, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 11, 2018
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTIONAaron I Vinik, Pauline M Camacho, Jaime A Davidson, et al.
BMJ Open|November 27, 2025
Evaluating pain and neurological function with high frequency 10 kHz spinal cord stimulation in the treatment of painful diabetic neuropathy: design of a multicentre, randomised controlled trial (PDN-Sensory)Rodica Pop-Busui, Erika A Petersen, Brian L Levy, et al.
Eclinicalmedicine|October 13, 2025
Spinal cord stimulation for the treatment of painful diabetic neuropathy and risk of major adverse cardiovascular events, mortality, amputation, infection and suicide: a retrospective cohort studyAlex E Henney, Bernhard Frank, David R Riley, et al.
Diabetes Care|September 30, 2010
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatmentsSolomon Tesfaye, Andrew J M Boulton, Peter J Dyck, et al.
Diabetes, Obesity & Metabolism|June 11, 2025
The use of SGLT2 inhibitors in people with diabetes-related foot disease: A Delphi-based consensus studyPatrick Highton, Ruksar Abdala, Rachel Evley, et al.
Diabetes/Metabolism Research and Reviews|February 16, 2024
Brain alterations in regions associated with end-organ diabetic microvascular disease in diabetes mellitus: A UK Biobank studyJamie Burgess, Christophe de Bezenac, Simon S Keller, et al.
Pageof 16